Richard W. Mott, Director at TREACE MEDICAL CONCEPTS, INC. (TMCI), sold 48,986 shares at $26.00 ($1.3M) on 2023-01-12, disclosed to the SEC on 2023-01-13.
Open-market sale of $1.3M TMCI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.00 | 42,467 | $1.1M | 86.7% |
| 2 | $26.00 | 6,519 | $169K | 13.3% |
| Total | $26.00 avg | 48,986 | $1.3M | 100% |
| Filing → |
| TMCI | BUY | 2024-05-13 | $1.1M | — | Filing → |
| TMCI | SELL | 2023-04-10 | $105K | — | Filing → |
| TMCI | SELL | 2023-04-05 | $415K | — | Filing → |